These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 30769198)

  • 21.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibilities of bloodstream isolates of Candida spp.: results from a multicenter active surveillance program in Andalusia.
    Flórez C; Martín-Mazuelos E; Ruiz M; Cisneros JM; Herrero M; García MV; Márquez M; Porras J; Martín P; Gamero C; Castón JJ;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):518-22. PubMed ID: 19477048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
    Astvad KMT; Hare RK; Arendrup MC
    Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
    Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for
    Delma FZ; Al-Hatmi AMS; Buil JB; van der Lee H; Tehupeiory-Kooreman M; de Hoog GS; Meletiadis J; Verweij PE
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of
    Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Dannaoui E; Garcia-Effron G; Guinea J; Kidd S; Pelaez T; Sanguinetti M; Meletiadis J; Botterel F; Bustamante B; Chen YC; Chakrabarti A; Chowdhary A; Chryssanthou E; Córdoba S; Gonzalez GM; Guarro J; Johnson EM; Kus JV; Lass-Flörl C; Linares-Sicilia MJ; Martín-Mazuelos E; Negri CE; Pfaller MA; Tortorano AM
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common
    Lim HJ; Shin JH; Kim MN; Yong D; Byun SA; Choi MJ; Lee SY; Won EJ; Kee SJ; Kim SH; Shin MG
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32900684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
    Arendrup MC; Friberg N; Mares M; Kahlmeter G; Meletiadis J; Guinea J;
    Clin Microbiol Infect; 2020 Nov; 26(11):1464-1472. PubMed ID: 32562861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
    Morris AJ; Rogers K; McKinney WP; Roberts SA; Freeman JT
    J Glob Antimicrob Resist; 2018 Sep; 14():72-77. PubMed ID: 29486358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL
    Clin Microbiol Infect; 2005 Jun; 11(6):486-92. PubMed ID: 15882199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candidaspp.
    Altinbaş R; Barış A; Şen S; Öztürk R; Kiraz N
    Turk J Med Sci; 2020 Dec; 50(8):2024-2031. PubMed ID: 32659879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.